BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3412139)

  • 1. [NMR-relaxation of blood serum in cancer patients].
    Papish EA; Temkina TIa; Kariakina NF
    Med Radiol (Mosk); 1988 Aug; 33(8):47-50. PubMed ID: 3412139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear magnetic resonance study of cancer: systemic effect on the proton relaxation times (T1 and T2) of human serum.
    de Certaines J; Bernard AM; Benoist L; Rivet P; Gallier J; Morin P
    Cancer Detect Prev; 1981; 4(1-4):267-71. PubMed ID: 7349785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnetic resonance characteristics of the blood serum of healthy persons].
    Kariakina NF; Papish EA; Temkina TIa
    Med Radiol (Mosk); 1988 Sep; 33(9):50-2. PubMed ID: 3419300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer.
    Engan T; Krane J; Klepp O; Kvinnsland S
    N Engl J Med; 1990 Apr; 322(14):949-53. PubMed ID: 2314446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
    Okunieff P; Zietman A; Kahn J; Singer S; Neuringer LJ; Levine RA; Evans FE
    N Engl J Med; 1990 Apr; 322(14):953-8. PubMed ID: 2314447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of morphology and relaxation times in NMR-imaging of the body.
    Rupp N; Reiser M; Stetter E
    Eur J Radiol; 1983 Feb; 3(1):68-76. PubMed ID: 6840110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
    Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
    Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicoradiologic significance of different study parameters in NMR tomography of the abdomen].
    Rupp N; Reiser M; Stetter E
    Rofo; 1983 Oct; 139(4):359-65. PubMed ID: 6413316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
    Pasanen PA; Kauppinen R; Eskelinen M; Partanen K; Pikkarainen P; Alhava E
    Anticancer Res; 1993; 13(3):763-8. PubMed ID: 8317910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of tumor burden on differentiation of T lymphocytes in the peripheral blood of patients with colorectal cancer].
    Cui M; Wang S; Ye YJ; Cui ZR; Ke Y
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):16-9. PubMed ID: 17403305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum osteoprotegerin levels in healthy controls and cancer patients.
    Lipton A; Ali SM; Leitzel K; Chinchilli V; Witters L; Engle L; Holloway D; Bekker P; Dunstan CR
    Clin Cancer Res; 2002 Jul; 8(7):2306-10. PubMed ID: 12114435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of peritumoral edema by proton T1 values with special remarks on time courses following intracranial surgery].
    Yoshida K; Inao S; Saso K; Motegi Y; Kaneoke Y; Furuse M
    No Shinkei Geka; 1987 Apr; 15(4):389-95. PubMed ID: 3614531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR relaxation times of water protons in human colon cancer cell lines and clones.
    Beall PT; Hazlewood CF; Rutzky LP
    Cancer Biochem Biophys; 1982; 6(1):7-12. PubMed ID: 6284348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood selenium in healthy persons and individuals with malignant diseases].
    Backović D; Stamenić V; Marmut Z; Jorga J
    Srp Arh Celok Lek; 1998; 126(1-2):18-22. PubMed ID: 9525078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of the feasibility of using the time of NMR spin-lattice relaxation in blood serum for the diagnosis of cancer].
    Galil-Ogly GA; Dmitriev GI; Koriakina NF; Bozhenko VK; Kalachikhina OD
    Vestn Akad Med Nauk SSSR; 1987; (12):43-6. PubMed ID: 3445698
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P; Orpana A; Joensuu H
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NMR relaxation in human blood serum a cancer diagnostic method].
    Revokatov OP; Gangardt MG; Murashko VV; Zhuravlev AK
    Biofizika; 1982; 27(2):336-8. PubMed ID: 7074164
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI.
    Barth M; Moser E
    Cell Mol Biol (Noisy-le-grand); 1997 Jul; 43(5):783-91. PubMed ID: 9298600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nuclear magnetic resonance relaxation times for human lung cancer and lung tissues].
    Matsuura Y; Shioya S; Kurita D; Ohta T; Suda S; Haida M; Fukuzaki M; Ohta Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32(12):1159-63. PubMed ID: 7853772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.